Perceptive Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Hold |
0
| – | – | – | 133 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 126 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 125 |
|
|
2017
Q4 | – | Sell |
-130,700
| Closed | -$1.32M | – | 152 |
|
|
2017
Q3 | $1.32M | Buy |
+130,700
| New | +$1.32M | 0.05% | 99 |
|
|
2017
Q2 | – | Sell |
-251,328
| Closed | -$5.05M | – | 160 |
|
|
2017
Q1 | $5.05M | Sell |
251,328
-590,800
| -70% | -$11.9M | 0.29% | 61 |
|
|
2016
Q4 | $13.1M | Sell |
842,128
-26,769
| -3% | -$417K | 0.93% | 29 |
|
|
2016
Q3 | $11.3M | Buy |
868,897
+19,547
| +2% | +$255K | 0.73% | 33 |
|
|
2016
Q2 | $5.82M | Hold |
849,350
| – | – | 0.4% | 49 |
|
|
2016
Q1 | $8.03M | Buy |
849,350
+290,904
| +52% | +$2.75M | 0.7% | 35 |
|
|
2015
Q4 | $5.62M | Sell |
558,446
-20,904
| -4% | -$210K | 0.42% | 50 |
|
|
2015
Q3 | $8.29M | Buy |
+579,350
| New | +$8.29M | 0.66% | 31 |
|